Hot Stocks Of The Day (JOSB, WCRX, GALE, ROSG, PPHM)

Jos. A. Bank Clothiers, Inc. (NASDAQ:JOSB) stock surged 17.06% to $48.73 after the company posted second quarter net income of $23.2 million as compared to $20.6 million for the second quarter of fiscal year 2011. Earnings per share increased 12.2% to $0.83 per share, as compared to $0.74 for the same quarter last year. Total sales increased 12.9% to $260.3 million from $230.7 million in the year ago period.

Can GENE Continue To Move Higher? Find Out Here

Warner Chilcott Plc (NASDAQ:WCRX) stock increased 3.99% to $13.41. Morgan Stanley reduced its rating on Warner Chilcott from Equal-weight to Underweight on August 21. Morgan Stanley downgraded WCRX from EW to UW as they see a more favorable risk-reward in other stocks. The analysts question Warner's LT prospects since they est. 80% of 2013E revs to be potentially threatened by generics, but future pipeline success and/or M&A could boost prospects.

Galena Biopharma Inc (NASDAQ:GALE) shares climbed 5.52% to $1.72 in the early hour after the company announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at BioCentury's 2012 NewsMakers in the Biotech Industry conference. The presentation will take place on Friday, September 7, 2012 at 11:30 a.m. EDT at the Millennium Broadway Hotel and Conference Center in New York, NY.

Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) shares gained 2.54%to $6.43. Aegis initiated coverage on shares of the company in a research note released last week. The firm issued a buy rating and a $16.00 price target on the stock. The company develops and commercializes diagnostic tests based on microRNAs. The Company has a wholly owned subsidiary, Rosetta Genomics Inc.

Can ROSG Continue To Move Higher? Find Out Here

Peregrine Pharmaceuticals (NASDAQ:PPHM) stock jumped 4.68% to $2.48. The 52 week trading range for the company is $0.39 - $3.21. The shares of the company soared 69% in the last one year. The company is a clinical-stage biopharmaceutical company that develops and manufactures monoclonal antibodies for the treatment of cancer and viral infections.